These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 924899)

  • 1. Stereochemical requirements in the antitumor anthracyclines.
    Penco S; Angelucci F; Vigeveni A; Arlandini E; Arcamone F
    J Antibiot (Tokyo); 1977 Sep; 30(9):764-6. PubMed ID: 924899
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor anthracyclines: recent developments.
    Arcamone F
    Med Res Rev; 1984; 4(2):153-88. PubMed ID: 6374338
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular structural effects involved in the interaction of anthracyclines with DNA.
    Zunino F; Di Marco A; Zaccara A
    Chem Biol Interact; 1979 Feb; 24(2):217-25. PubMed ID: 428012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor agents. 2. Bisguanylhydrazones of anthracene-9,10-dicarboxaldehydes.
    Murdock KC; Child RG; Lin Y; Warren JD; Fabio PF; Lee VJ; Izzo PT; Lang SA; Angier RB; Citarella RV; Wallace RE; Durr FE
    J Med Chem; 1982 May; 25(5):505-18. PubMed ID: 6806475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of anthracyclines relative to effects on macromolecular syntheses.
    Crooke ST; Duvernay VH; Galvan L; Prestayko AW
    Mol Pharmacol; 1978 Mar; 14(2):290-8. PubMed ID: 642929
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of biochemical and biological methods in the evaluation of new anthracycline drugs.
    Di Marco A; Zunino F; Casazza AM
    Antibiot Chemother (1971); 1978; 23():12-20. PubMed ID: 206196
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and antitumor activity of new anthracyclines.
    Florent JC; Genot A; Monneret C
    J Antibiot (Tokyo); 1989 Dec; 42(12):1823-30. PubMed ID: 2621164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antitumor activity of 9-[(carbamoyloxy)alkyl]anthracyclines: a novel class of anthracycline derivatives.
    Adams N; Blake C; Broadhurst MJ; Bushnell DJ; Hassall CH; Hartmann HR; Keech E; Stratton AR; Thomas GJ
    J Med Chem; 1990 Sep; 33(9):2380-4. PubMed ID: 2391682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
    Adams N; Blake C; Broadhurst MJ; Bushnell DJ; Hassall CH; Hartmann HR; Keech E; Stratton AR; Thomas GJ
    J Med Chem; 1990 Sep; 33(9):2375-9. PubMed ID: 2391681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antifungal antibiotic BMY-28567. Structural study and biological activities.
    Oki T; Saitoh K; Tomatsu K; Tomita K; Konishi M; Kawaguchi H
    Ann N Y Acad Sci; 1988; 544():184-7. PubMed ID: 3214068
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on anthracenes. 2. Synthesis and cytotoxic evaluation of 9-acyloxy 1,8-dichloroanthracene derivatives.
    Huang HS; Chiu HF; Hwang JM; Jen YM; Tao CW; Lee KY; Lai YL
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1346-8. PubMed ID: 11605668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoelectronic factors influencing the biological activity and DNA interaction of synthetic antitumor agents modeled on CC-1065.
    Warpehoski MA; Gebhard I; Kelly RC; Krueger WC; Li LH; McGovren JP; Prairie MD; Wicnienski N; Wierenga W
    J Med Chem; 1988 Mar; 31(3):590-603. PubMed ID: 3346875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of DNA sequence selective alkylation by kapurimycin A3 analogs.
    Okamoto A; Nakatani K; Saito I
    Nucleic Acids Symp Ser; 1997; (37):27-8. PubMed ID: 9585982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New anthracycline antibiotics, auramycins and sulfurmycins. II. Isolation and characterization of 10 minor components (C approximately G).
    Hoshino T; Tazoe M; Nomura S; Fujiwara A
    J Antibiot (Tokyo); 1982 Oct; 35(10):1271-9. PubMed ID: 7186414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical modification of hitachimycin. III. Synthesis and antitumor activities of amino acyl derivatives.
    Shibata K; Satsumabayashi S; Sano H; Komiyama K; Yang ZB; Nakagawa A; Omura S
    J Antibiot (Tokyo); 1989 Jul; 42(7):1114-23. PubMed ID: 2753817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaction of the antitumor antibiotic CC-1065 with DNA: structure of a DNA adduct with DNA sequence specificity.
    Hurley LH; Reynolds VL; Swenson DH; Petzold GL; Scahill TA
    Science; 1984 Nov; 226(4676):843-4. PubMed ID: 6494915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actinomycin and antitumor antibiotics.
    Young CW
    Am J Clin Pathol; 1969 Aug; 52(2):130-7. PubMed ID: 5798361
    [No Abstract]   [Full Text] [Related]  

  • 18. New anthracycline antibiotics 10-epi-oxaunomycin and 10-epi-11-deoxyoxaunomycin.
    Johdo O; Nishida H; Okamoto R; Yoshimoto A; Takeuchi T
    J Antibiot (Tokyo); 1995 Oct; 48(10):1153-8. PubMed ID: 7490224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparsomycin analogs. V. Synthesis and antitumor activity of (E)-beta-(pyrimidin-5-yl)acrylamides.
    Kanatomo S; Wada A; Hamaoka Y; Nagai S; Fukuda S; Tanaka M; Sasaki T
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4421-5. PubMed ID: 3246010
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA binding by antitumor anthracene derivatives.
    Wunz TP; Craven MT; Karol MD; Hill GC; Remers WA
    J Med Chem; 1990 Jun; 33(6):1549-53. PubMed ID: 2342051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.